Ocular Therapeutix Inc’s recently made public that its 10% Owner SUMMER ROAD LLC acquired Company’s shares for reported $7.0 million on Feb 26 ’24. In the deal valued at $7.52 per share,930,851 shares were bought. As a result of this transaction, SUMMER ROAD LLC now holds 8,591,401 shares worth roughly $ 44.85 million.
Then, Mattessich Antony C. sold 18,338 shares, generating $90,773 in total proceeds. Upon selling the shares at $4.95, the President and CEO now owns 427,943 shares.
Before that, Ozden Rabia Gurses sold 7,764 shares. Ocular Therapeutix Inc shares valued at $38,432 were divested by the Chief Medical Officer at a price of $4.95 per share. As a result of the transaction, Ozden Rabia Gurses now holds 92,767 shares, worth roughly $0.48 million.
BofA Securities initiated its Ocular Therapeutix Inc [OCUL] rating to a Buy in a research note published on February 09, 2024; the price target was $15. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who began to cover the stock in late April with a ‘”an Outperform”‘ rating. H.C. Wainwright revised its rating on August 10, 2021. It rated OCUL as “a Buy” which previously was an “a Neutral”.
Price Performance Review of OCUL
On Friday, Ocular Therapeutix Inc [NASDAQ:OCUL] saw its stock fall -10.92% to $5.22. Over the last five days, the stock has lost -34.67%. Ocular Therapeutix Inc shares have risen nearly 17.04% since the year began. Nevertheless, the stocks have fallen -10.31% over the past one year. While a 52-week high of $11.31 was reached on 03/06/24, a 52-week low of $2.00 was recorded on 01/19/24. SMA at 50 days reached $8.63, while 200 days put it at $4.92. A total of 9.13 million shares were traded, compared to the trading of 6.07 million shares in the previous session.
Levels Of Support And Resistance For OCUL Stock
The 24-hour chart illustrates a support level at 4.83, which if violated will result in even more drops to 4.45. On the upside, there is a resistance level at 5.75. A further resistance level may holdings at 6.29. The Relative Strength Index (RSI) on the 14-day chart is 19.18, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.53, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 93.94%. Stochastics %K at 3.14% indicates the stock is a buying.
